Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients.

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients. BMC Med Genomics. 2010 May 06; 3:16.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.